EquityZen Growth Technology Fund LLC - Series 832
Raised
$368K
Investors
12
Min Invest
$10,001
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 832 is a Delaware pooled investment fund vehicle filed by EquityZen Advisors on 2021-05-20, raising $368K from 12 investors with a $10K minimum investment under Rule 506(b) and Section 3(c)(1). This is part of EquityZen's pre-IPO secondary market platform, which operates 1,889+ related EDGAR entities enabling accredited investors to access private company shares.
This vehicle uses the standard 506(b)/3(c)(1) exemption pattern common to pre-IPO secondary market funds, with a $10K minimum investment positioning it at the lower end of accredited investor accessibility. The per-investor average of ~$31K reflects typical retail-accredited participation in EquityZen's series SPV model, where each series typically targets a single late-stage private company.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
